TelePrEP is a service that provides pre-exposure prophylaxis (PrEP) medication to individuals at risk of contracting HIV via remote telemedicine appointments. It allows patients to receive PrEP medication and support from a healthcare provider without having to visit a clinic in person, making it more convenient and accessible.

TelePrEP in Practice is a webinar that covers the benefits of telePrEP, as well as strategies and best practices for integrating telePrEP into your organization's services.

Release Date: May 17, 2023

Expiration Date: May 17, 2024

UAN# JA4008162-9999-23-231-H02-P

Target Audience This activity is intended for the following professionals practicing in the state of Maryland: Physician, PA, Registered Nurse, Nurse Practitioner/APRN, Pharmacist, Psychologist, Social Worker, Dentist.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Discuss how telehealth has transformed access to quality HIV prevention services.
  • Identify aspects of provider readiness to deliver telePrEP, including availability of telehealth technical resources for providers.
  • Describe opportunities and strategies to leverage existing resources and infrastructure development to support the extension/utilization of telehealth services for PrEP by the healthcare team.
  • Describe model practices for the delivery of effective and engaging telePrEP services, including hybrid (in-person and virtual) models.

Faculty Christopher Hall, MD, MS, AAHIVS and Keith Taylor

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

The faculty presenters have nothing to disclose.

The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.

Joint Accreditation Statement

Jointly Accredited Provider: Interprofessional Continuing EducationIn support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour.

Continuing Pharmacy Education Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

Continuing Physician Assistant Education

AAPA Category 1 CMEPostgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Continuing Social Work Education

ACE: approved continuing educationAs a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.

Disclosure of Unlabeled Use This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.